Long‐term risk of upper gastrointestinal bleeding after Helicobacter pylori eradication: a population‐based cohort study

Summary Background The long‐term effects of H. pylori eradication in preventing upper GI bleeding (UGIB) remains unknown. Aim To determine the long‐term risks of UGIB after H. pylori eradication Methods We included all patients who had received clarithromycin‐containing triple therapy for the treatm...

Full description

Saved in:
Bibliographic Details
Published inAlimentary pharmacology & therapeutics Vol. 54; no. 9; pp. 1162 - 1169
Main Authors Jiang, Fang, Guo, Chuan‐Guo, Cheung, Ka Shing, Leung, Wai K.
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.11.2021
Subjects
Online AccessGet full text
ISSN0269-2813
1365-2036
1365-2036
DOI10.1111/apt.16604

Cover

More Information
Summary:Summary Background The long‐term effects of H. pylori eradication in preventing upper GI bleeding (UGIB) remains unknown. Aim To determine the long‐term risks of UGIB after H. pylori eradication Methods We included all patients who had received clarithromycin‐containing triple therapy for the treatment of H. pyliori infection between 2003 and 2012, without subsequent need for re‐treatment. We included a propensity score (PS)‐matched endoscopy cohort of H. pylori‐negative patients as controls. The primary endpoint was the risk of subsequent UGIB. A multivariable Cox model was used to compute the hazard ratio (HR) of UGIB. Results We included 62 738 H. pylori‐eradicated and 62 738 PS‐matched H. pylori‐negative patients, with a median follow‐up of 8.1 years (IQR 5.5‐10.6). The incidence of UGIB was 20.8 (95% CI 19.5‐22.1) and 13.6 (95% CI 12.7‐14.7) per 10 000 person‐years in H. pylori‐eradicated and H. pylori‐negative patients, respectively. Compared to controls, H. pylori‐eradicated patients had a significantly higher risk of UGIB (HR: 1.65, 95% CI 1.49‐1.83). The risk of UGIB in H. pylori‐eradicated patients increased after the first 2 years of follow up (HR: 2.18, 95% CI 1.91‐2.49). Age‐stratified analysis showed that patients >45 years had higher UGIB risk, even after eradication. Conclusions Despite H. pylori eradication, the long‐term risk of UGIB was still higher than in H. pylori‐negative control subjects. The protective effects of eradication therapy in preventing UGIB appeared to be limited to younger patients, and to within the first 2 years after eradication. Despite H. pylori eradication, the long‐term risk of UGIB was still higher than H. pylori‐negative subjects. The protective effects of H. pylori eradication in preventing UGIB appeared to belimited to within the first 2 years after eradication.
Bibliography:The Handling Editor for this article was Dr Colin Howden, and it was accepted for publication after full peer‐review.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0269-2813
1365-2036
1365-2036
DOI:10.1111/apt.16604